8 research outputs found

    List of the 31 European countries whose outputs were examined in this study with their ISO2 codes.

    No full text
    <p>List of the 31 European countries whose outputs were examined in this study with their ISO2 codes.</p

    Numbers of RESPI papers in the three main non-communicable respiratory diseases from each of the 18 leading European countries, 2002–13, fractional counts, and their relative commitment (RC) to research on each disease relative to their output in RESPI and to the European average.

    No full text
    <p>Numbers of RESPI papers in the three main non-communicable respiratory diseases from each of the 18 leading European countries, 2002–13, fractional counts, and their relative commitment (RC) to research on each disease relative to their output in RESPI and to the European average.</p

    Citations of European RESPI papers on 45 European respiratory clinical guidelines (CGs), and comparison with research outputs (Res): percentages of EUR31 total.

    No full text
    <p>Citations of European RESPI papers on 45 European respiratory clinical guidelines (CGs), and comparison with research outputs (Res): percentages of EUR31 total.</p

    List of leading funders of European respiratory disease research, 2009–13, with fractional counts of numbers of papers (N) and estimates of annual research funding for European papers (€ million).

    No full text
    <p>List of leading funders of European respiratory disease research, 2009–13, with fractional counts of numbers of papers (N) and estimates of annual research funding for European papers (€ million).</p

    European Union support for respiratory disease research, 2009–13: numbers of papers (left columns) and percent of papers for individual countries (EU, %, right columns).

    No full text
    <p>European Union support for respiratory disease research, 2009–13: numbers of papers (left columns) and percent of papers for individual countries (EU, %, right columns).</p

    Mean numbers of funding acknowledgments per paper, explicit and implicit, on the basis of integer paper counts (INT) and of fractional counts (FRAC) for the 20 leading European producers of RESPI papers, 2009–13.

    No full text
    <p>Mean numbers of funding acknowledgments per paper, explicit and implicit, on the basis of integer paper counts (INT) and of fractional counts (FRAC) for the 20 leading European producers of RESPI papers, 2009–13.</p

    Incidence of cystic fibrosis in selected European countries [36].

    No full text
    <p>Incidence of cystic fibrosis in selected European countries [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0154197#pone.0154197.ref036" target="_blank">36</a>].</p

    Main sectors supporting respiratory disease research in 11 leading European countries, 2009–13.

    No full text
    <p>GOV = public sector (including local authorities), PNP = private-non-profit, CEC = European Union, INDY = industry (mainly pharma).</p
    corecore